Meeting of the National Advisory Council for Healthcare Research and Quality, 40289-40290 [2020-14336]

Download as PDF Federal Register / Vol. 85, No. 129 / Monday, July 6, 2020 / Notices assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington DC 20551–0001, not later than August 5, 2020. A. Federal Reserve Bank of Richmond (Adam M. Drimer, Assistant Vice President) 701 East Byrd Street, Richmond, Virginia 23219. Comments can also be sent electronically to Comments.applications@rich.frb.org: 1. First Citizens Bancshares, Inc., Raleigh, North Carolina, to retain 5.05 percent and acquire solely as a result of stock redemptions up to 9 percent of the voting shares of Commerce West Bank, Irvine, California. Board of Governors of the Federal Reserve System, June 30, 2020. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2020–14450 Filed 7–2–20; 8:45 am] BILLING CODE P Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than July 21, 2020. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Nancy Kay Toppenberg, Newton, Iowa, together with Linda Louise Fleagle and Jerry Lee Fleagle, both of Coralville, Iowa, and Brian Toppenberg, Norwalk, Iowa; as a group acting in concert, to acquire voting shares of First State Bank Holding Company, and thereby indirectly acquire voting shares of First State Bank, both of Lynnville, Iowa. B. Federal Reserve Bank of San Francisco (Sebastian Astrada, Director, Applications) 101 Market Street, San Francisco, California 94105–1579: 1. Selwyn Isakow, LaJolla, California; to acquire additional voting shares of Private Bancorp of America, Inc., and thereby indirectly acquire voting shares of Calprivate Bank, both of LaJolla, California. Board of Governors of the Federal Reserve System, June 30, 2020. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2020–14434 Filed 7–2–20; 8:45 am] BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM khammond on DSKJM1Z7X2PROD with NOTICES Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company DEPARTMENT OF HEALTH AND HUMAN SERVICES The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the VerDate Sep<11>2014 04:41 Jul 03, 2020 Jkt 250001 Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), Health and Human Services (HHS). ACTION: Notice of public meeting. AGENCY: PO 00000 Frm 00106 Fmt 4703 Sfmt 4703 40289 This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Tuesday, July 14, 2020, from 10:00 a.m. to 1:15 p.m. ADDRESSES: The meeting will be held virtually. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. Closed captioning will be provided during the meeting. If another reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Monday, July 6, 2020. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: SUMMARY: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Tuesday, July 14, 2020, the Council meeting will convene at 10:00 E:\FR\FM\06JYN1.SGM 06JYN1 40290 Federal Register / Vol. 85, No. 129 / Monday, July 6, 2020 / Notices a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with an update on AHRQ’s recent accomplishments in Research, Practice Improvements and Data and Analytics. The agenda will also include an update on AHRQ and COVID–19 and a presentation on Improving Health Services Research Across the Federal Enterprise. The meeting will adjourn at 1:15 p.m. The meeting is open to the public. For information regarding how to access the meeting as well as other meeting details, including information on how to make a public comment, please go to https://www.ahrq.gov/news/ events/nac/. The final agenda will be available on the AHRQ website no later than Tuesday, July 7, 2020. Dated: June 29, 2020. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2020–14336 Filed 7–2–20; 8:45 am] BILLING CODE 4160–90–P The meeting will be held on July 22, 2020, 10:00 a.m. to 1:15 p.m., EDT (OPEN) and July 22, 2020, 2:00 p.m. to 4:30 p.m., EDT (CLOSED). DATES: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention FOR FURTHER INFORMATION CONTACT: khammond on DSKJM1Z7X2PROD with NOTICES Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC); July 22, 2020, from 10:00 a.m. to 01:00 p.m., EDT (OPEN) and July 22, 2020, from 01:45 p.m. to 04:15 p.m., EDT (CLOSED), Teleconference 1–800–369– 3110; Participant Code 7563795, which was published in the Federal Register on May 20, 2020, Volume 85, Number 98, pages 30709–30710. The meeting is being amended to extend the oral public comment period during the open session, change the time of the closed session, and request written comments by email submission; and should read as follows: SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). This meeting is partially open and partially closed to the public. The open session is limited only by the ports available. There will be 2,000 telephone ports available. There will also be 55 minutes allotted for oral public comments at the end of VerDate Sep<11>2014 04:41 Jul 03, 2020 Jkt 250001 the open session from 12:20 p.m. to 1:15 p.m., EDT on July 22, 2020. In addition, written comments may also be submitted for the meeting record. Written comments should be emailed to NCIPCBSC@cdc.gov and will be accepted until July 28, 2020, 5:00 p.m., EDT. The public is encouraged to register to participate by telephone and/or provide oral public comment using the registration form available at the link provided: https:// www.surveymonkey.com/r/NVV9XM2. Individuals registered to provide oral public comment will be called upon to speak based on the order of registration. After persons who have registered have spoken, any remaining time in the oral public comment period will be used for members of the public who have not registered to speak but wish to offer comment. Individuals making oral public comment during the meeting will have a 2-minute speaking limit to allow for as many comments as possible. Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway, NE, Mailstop S106–9, Atlanta, GA 30341, Telephone (770) 488–3953, Email address: NCIPCBSC@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–14447 Filed 7–2–20; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00107 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2020–0051] Request for Information Concerning Personnel and the Retention of Next Generation Sequencing Data in Clinical and Public Health Laboratories; Extension of Comment Period Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: On May 15, 2020, the Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS) published a notice in the Federal Register requesting public comment on the Request for Information Concerning Personnel and the Retention of Next Generation Sequencing Data in Clinical and Public Health Laboratories (85 FR 29456). Written and electronic comments were to be received on or before July 14, 2020. HHS/CDC has received a request asking for a 60-day extension of the comment period. In consideration of this request, HHS/CDC is extending the comment period to September 14, 2020. DATES: Written comments must be received on or before September 14, 2020. SUMMARY: You may submit comments, identified by Docket No. CDC–2020– 0051 by any of the following methods only. CDC does not accept comment by email. Internet: Access the Federal eRulemaking portal at https:// www.regulations.gov. Follow the instructions for submitting comments. Mail: Heather Stang, MS, MT, Division of Laboratory Systems, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–3, Atlanta, GA 30329. Docket No. CDC– 2020–0051. All relevant comments received will be posted publicly without change, including any personal or proprietary information provided. To download an electronic version of the plan, please access https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, MT, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–3, Atlanta, GA 30329, telephone (800) 232–4636; email: dlsinquiries@cdc.gov. ADDRESSES: E:\FR\FM\06JYN1.SGM 06JYN1

Agencies

[Federal Register Volume 85, Number 129 (Monday, July 6, 2020)]
[Notices]
[Pages 40289-40290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14336]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Health and 
Human Services (HHS).

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the National Advisory 
Council for Healthcare Research and Quality.

DATES: The meeting will be held on Tuesday, July 14, 2020, from 10:00 
a.m. to 1:15 p.m.

ADDRESSES: The meeting will be held virtually.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at 
(301) 427-1998 or [email protected].
    Closed captioning will be provided during the meeting. If another 
reasonable accommodation for a disability is needed, please contact the 
Food and Drug Administration (FDA) Office of Equal Employment 
Opportunity and Diversity Management on (301) 827-4840, no later than 
Monday, July 6, 2020. The agenda, roster, and minutes will be available 
from Ms. Heather Phelps, Committee Management Officer, Agency for 
Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 
20857. Ms. Phelps' phone number is (301) 427-1128.

SUPPLEMENTARY INFORMATION:

I. Purpose

    In accordance with section 10(a) of the Federal Advisory Committee 
Act, 5 U.S.C. App., this notice announces a meeting of the National 
Advisory Council for Healthcare Research and Quality (the Council). The 
Council is authorized by Section 941 of the Public Health Service Act, 
42 U.S.C. 299c. In accordance with its statutory mandate, the Council 
is to advise the Secretary of the Department of Health and Human 
Services and the Director of AHRQ on matters related to AHRQ's conduct 
of its mission including providing guidance on (A) priorities for 
health care research, (B) the field of health care research including 
training needs and information dissemination on health care quality and 
(C) the role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Tuesday, July 14, 2020, the Council meeting will convene at 
10:00

[[Page 40290]]

a.m., with the call to order by the Council Chair and approval of 
previous Council summary notes. The meeting will begin with an update 
on AHRQ's recent accomplishments in Research, Practice Improvements and 
Data and Analytics. The agenda will also include an update on AHRQ and 
COVID-19 and a presentation on Improving Health Services Research 
Across the Federal Enterprise. The meeting will adjourn at 1:15 p.m. 
The meeting is open to the public. For information regarding how to 
access the meeting as well as other meeting details, including 
information on how to make a public comment, please go to https://www.ahrq.gov/news/events/nac/.
    The final agenda will be available on the AHRQ website no later 
than Tuesday, July 7, 2020.

    Dated: June 29, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-14336 Filed 7-2-20; 8:45 am]
BILLING CODE 4160-90-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.